Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults
- 14 August 2007
- Vol. 25 (33), 6164-6166
- https://doi.org/10.1016/j.vaccine.2007.06.004
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Postvaccine Genetic Structure ofStreptococcus pneumoniaeSerotype 19A from Children in the United StatesThe Journal of Infectious Diseases, 2005
- Approach to Validating an Opsonophagocytic Assay for Streptococcus pneumoniaeClinical and Vaccine Immunology, 2005
- Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal PolysaccharidesClinical and Vaccine Immunology, 2003
- Significant Variation in Serotype‐Specific Immunogenicity of the Seven‐ValentStreptococcus pneumoniaeCapsular Polysaccharide–CRM197Conjugate Vaccine Occurs Despite Vigorous T Cell Help Induced by the Carrier ProteinThe Journal of Infectious Diseases, 2003
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adultsVaccine, 2001
- The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part IIClinical Infectious Diseases, 2000
- Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part IClinical Infectious Diseases, 2000
- Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serumVaccine, 1998
- Effect of Human Immunodeficiency Virus Type 1 Infection on the Antibody Response to a Glycoprotein Conjugate Pneumococcal Vaccine: Results from a Randomized TrialThe Journal of Infectious Diseases, 1996